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INTRODUCTION 
Cancer is an unrestricted growth of cells, which 
march into other tissues and cause destruction. 
Every hour, a person dies of oral cancer in the 
United States1 and approximately 14 deaths per 
hour are reported in India.2 
 
Various risk factors for oral cancer are well known. 
Factors like tobacco chewing, smoking, alcohol 
consumption and actinic radiation have been 
extensively studied and clinically validated. 
However, with growing awareness, these 
traditional factors are declining. Sadly, this does 
not taper off the incidence of oral cancer, which 
has led to emergence of new risk factors, one of 
them being Human Papilloma Virus.3 
 
In addition to its role in carcinogenesis in cervical 
cancer, HPV has been shown to be a significant 
risk factor for oral and oropharyngeal cancers. 
 
KNOW THE MOLECULAR BIOLOGY 
The human papilloma virus (HPV) belongs to the 
family of double-stranded DNA viruses. It infects 
the epithelial cells of skin and mucosa. The HPV 
family contains around 200 strains but it is 
important to note that only nine out of them are 
high risk and associated with cancers. Amongst 
them HPV16 is the most strongly related. A recent  
 
 
 
NHANES    study    suggests,    roughly   2.1 million  
Americans on a given day have an oral HPV16 
infection.4 
 
HPV being epitheliotropic in nature infects basal 
layer of the squamous epithelium. It integrates 
with the DNA of the host cell, thereby 
dysregulating the expression of oncoproteins E6 
and E7. This results in the functional inactivation 
of human tumor-suppressor proteins p16, p53 and 
pRb, which culminates to cell immortalization. 
However, it has been documented that the 
development of cancer in HPV infected cell may 
take over 10 years and essentially requires multiple 
additive crucial epigenetic alterations.5 
 
HPV AND ORAL CANCER 
HPV is the leading cause of oropharyngeal cancers 
and a few of oral cavity cancers, particularly 
occurring at the base of tongue and the tonsillar 
region. Albeit it affects both males and females but 
middle-aged males (30-55 yrs) are 4 times more 
susceptible. In contrast with HPV negative oral 
cancers, HPV positive cancers occurs in healthy, 
non-smokers and non-drinkers. 
 
Risk Factors  
Increased number of sexual partners predisposes  
 
 
 
HPV is the leading cause of oropharyngeal cancers and a few oral cavity cancers with increasing  mortality across the globe. The risk 
factors for oral cancer are well known. Factors like tobacco chewing, smoking, alcohol consumption and actinic radiation have been 
extensively studied and clinically validated. However , Recently HPV has been shown to be a significant risk factor for oral and 
oropharyngeal cancers. The HPV family contains around 200 strains but it is important to note that only nine out of them are high 
risk and associated with cancers. Amongst them HPV16 is most strongly related with oral cancer. HPV associated cancers are 
different from cancers originating from other etiologies and thus , require a novel multidisciplinary treatment approach. The article 
is a review of Molecular Biology ,  Risk Factors ,Clinical aspects ,Diagnosis ,and Treatment of HPV associated Oral cancer . 
 
KEYWORDS: Human Papilloma Virus, HPV16, Oral cancer, Oropharyngeal Cancer 
 
K 
Oral Cancer and HPV Connection: A Review 
REVIEW ARTICLE 
 
A 
B 
S
T
R
A
C
T 
ISSN: 2456-8090 (online) 
International Healthcare Research Journal 2017;1(8):240-242. 
DOI: 10.26440/IHRJ/01_08/122 
SAVITA SHARMA1 
QR CODE 
 
240 
 IHRJ Volume 1 Issue 8 2017 
to the risk of being infected with HPV.  
 
HIV infected patients and those with 
immunosuppressant drug therapy are more 
vulnerable for HPV infection. 
 
Clinical aspects 
Besides the conventional signs and symptoms of 
oral cancer, HPV associated cancers differ in the 
following facets: 
 Some authors have demonstrated a high 
prevalence of HPV in erosive and atrophic 
lesions. 
 HPV associated cancers are more likely to 
present with an early stage (TI/T2) tumor, 
which can be comparatively smaller. 
 There is a more advanced nodal involvement 
(N2/N3) and the appearance of affected lymph 
nodes is often cystic. 
 These are more aggressive in nature. 
 HPV associated cancers are less likely to have 
a second malignancy. 
 
DIAGNOSIS 
OSCC cannot be diagnosed radiographically, so 
histopathological methods and serological tests 
are used. Histologically, its presence denotes a 
subset of basaloid squamous carcinoma with a 
more indolent behavior. 
 
There are various serological tests for detection of 
HPV, but they differ in their analytical sensitivity. 
Immunohistochemistry for p16 (a tumor 
suppressor protein overexpressed in HPV 
associated cancers) is said to be highly sensitive 
for HPV and can be used routinely as a surrogate 
for HPV status. Confirmation is done using 
standard methods based on PCR assays, in-situ 
Hybridization, and Southern Blot Hybridization 
for detection of HPV DNA.6 
 
STAGING  
The emerging evidences suggest that the 
contemporary TNM staging for oral cancer 
designed empirically for non-HPV associated oral 
cancer seems unsuited for HPV-related OSCC. 
The basis of which is suggested to be the improved 
prognosis of HPV associated OSCC, despite 
presenting at advanced stages.  
 
Provisionally, an alternative staging system for 
HPV-related OSCC has been developed by the 
International Collaboration on Oropharyngeal 
cancer Network for Staging (ICON-S).7 
 
TREATMENT  
Treatment of oral cancers require a 
multidisciplinary approach. The therapeutic 
treatment modalities are generally surgery and 
radiation with or without concomitant 
chemotherapy. 
 
Although, the treatment for HPV associated oral 
cancers is currently the same as for those with 
HPV negative cancers, literature suggests that 
there is an increased sensitivity of HPV positive 
oral cancers to chemo-radiotherapy as compared 
to their negative counterparts. HPV positive oral 
cancers thus have a better prognosis and survival 
rate as compared to HPV negative ones.8 
 
We can conclude that knowledge of HPV status of 
an oral cancer patient is vital and imperative as it 
can both guide and predict the outcome of 
therapy. 
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